ArticleEClinicalMedicine2025

Safety and efficacy of GST-HG141, a novel HBV capsid assembly modulator, for the treatment of chronic hepatitis B patients with low-level viremia: a randomized, double-blind, placebo-controlled, multicenter phase II study.

Chong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.